ArticleJournal of clinical medicine2022

Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study.

Josefien Hessels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.